Bruni R, Hernández-Juviel J M, Tanoviceanu R, Walther F J
Department of Pediatrics, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
Mol Genet Metab. 1998 Feb;63(2):116-25. doi: 10.1006/mgme.1997.2657.
Synthetic surfactant peptides SP-B1-78 and SP-C1-31 in a standard phospholipid mixture have been employed to examine the correlation between in vitro surface activity and in vivo function of synthetic surfactant preparations in the isolated rat lung and premature rabbit models of respiratory distress syndrome. Monolayer techniques showed that SP-B peptides have a high propensity for association with a phospholipid structure. By dynamic respreading, synthetic SP-B and SP-C showed rapid spreading and attained low surface tensions. Used as replacement surfactants in two animal models, these synthetic surfactant preparations partially restored lung compliance in lavaged rats and premature rabbits better than a pure phospholipid preparation and to a degree comparable to clinical surfactant, measured by pressure/volume curves. Our data confirm that in vitro functional determinations of synthetic surfactant peptides are instrumental in the preparation of replacement surfactants, and that dispersions thus selected represent viable therapeutic alternatives to current treatments for respiratory distress syndrome.
在标准磷脂混合物中的合成表面活性剂肽SP-B1-78和SP-C1-31已被用于研究合成表面活性剂制剂在离体大鼠肺和早产兔呼吸窘迫综合征模型中的体外表面活性与体内功能之间的相关性。单层技术表明,SP-B肽与磷脂结构具有高度的结合倾向。通过动态再铺展,合成的SP-B和SP-C显示出快速铺展并达到低表面张力。在两种动物模型中用作替代表面活性剂时,这些合成表面活性剂制剂比纯磷脂制剂能更好地部分恢复灌洗大鼠和早产兔的肺顺应性,并且在通过压力/容积曲线测量时,恢复程度与临床表面活性剂相当。我们的数据证实,合成表面活性剂肽的体外功能测定有助于替代表面活性剂的制备,并且如此选择的分散体代表了目前呼吸窘迫综合征治疗方法的可行治疗替代方案。